Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vaginal effervescence tablet composition containing solid lipid

A technology of solid lipids and effervescent tablets, which is applied to medical preparations containing active ingredients, drug combinations, and medical preparations with non-active ingredients, etc. It can solve the problem that the adhesion of effervescent tablets affects drug distribution, jelly Difficult to remove, uneven drug distribution and other problems, to achieve the effect of low viscosity, prolonged effect, and easy removal

Inactive Publication Date: 2008-09-10
CHINA PHARM UNIV
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the one hand, the formation of thick jelly will make the effervescent tablet have strong adhesion and affect the distribution of the drug to the vaginal wall, resulting in uneven distribution of the drug on the vaginal mucous membrane; on the other hand, the jelly is difficult to remove clean, affecting patient hygiene

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vaginal effervescence tablet composition containing solid lipid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] Formula of Nystatin Vaginal Effervescent Tablet 1

[0103] Preparation Content of ingredients in each tablet (mg)

[0104] Nystatin 20

[0105] 888 ATO 95

[0106] Lactose 902

[0107] Sodium bicarbonate 73

[0108] Tartaric acid 67

[0109] Sodium Lauryl Sulfate 18

[0110] Di-tert-butyl-p-cresol 2

[0111] Magnesium Stearate 20

[0112] Preparation method: mix nystatin, part of lactose, and di-tert-butyl-p-cresol, use absolute ethanol solution to make soft material, pass through 60 mesh to make wet granules, dry at 30°C for 60 minutes, and pass through 60 mesh for granulation. Add sodium lauryl sulfate, sodium bicarbonate, tartaric acid, 888ATO, magnesium stearate and remaining lactose are mixed evenly and compressed into diamond-shaped tablets. The hardness of gained tablet is controlled at 10-12kg / mm 2 .

[0113] The nystatin vaginal effervescent tablet that adopts embodiment 1 to prepare carries out quality research, and the results are as follows:

...

Embodiment 2

[0116] Formulation of Secnidazole Vaginal Effervescent Tablet 2

[0117] Preparation Content of ingredients in each tablet (mg)

[0118] Secnidazole 250

[0119] ATO 5 200

[0120] Lactose 540

[0121] Sodium bicarbonate 105

[0122] Citric acid 85

[0123] Sodium Lauryl Sulfate 20

[0124] Magnesium Stearate 20

[0125] Preparation method: secnidazole, ATO 5, lactose, sodium bicarbonate, citric acid, sodium lauryl sulfate and magnesium stearate were mixed in a container for 25 minutes, then transferred to a tablet machine and compressed into diamond-shaped tablets. The hardness of gained tablet is controlled at 9-11kg / mm 2 .

[0126] The obtained secnidazole vaginal effervescent tablet that adopts embodiment 2 to prepare carries out quality research, and the results are as follows:

[0127] project

Embodiment 3

[0129] Formulation of Clindamycin Phosphate Vaginal Effervescent Tablet 3

[0130] Preparation Content of ingredients in each tablet (mg)

[0131] Clindamycin Phosphate 100

[0132] 888 ATO 190

[0133] Lactose 510

[0134] Povidone K30 30

[0135] Sodium bicarbonate 80

[0136] Tartaric acid 66

[0137] Sodium Lauryl Sulfate 20

[0138] Magnesium Stearate 20

[0139] Preparation method: clindamycin phosphate, 888 ATO, part of lactose, tartaric acid, and sodium lauryl sulfate were mixed in a container for 25 minutes, and an appropriate amount of 5% povidone K30 aqueous solution was added to prepare a soft material, granulated through a 40-mesh sieve, and air-dried at 50 degrees for 45 minutes , after taking out, pass through a 40-mesh sieve to obtain granule I. In addition, put sodium bicarbonate and part of lactose in a container and mix for 25 minutes, add an appropriate amount of 5% povidone K30 aqueous solution to prepare a soft material, pass through a 40-mesh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
hardnessaaaaaaaaaa
hardnessaaaaaaaaaa
hardnessaaaaaaaaaa
Login to View More

Abstract

The invention provides a vaginal effervescent tablet composition that comprises 100 weight portions of active drug ingredients and 20-1000 weight portions of solid lipid. The vaginal effervescent tablet composition of the invention can be released in vagina slowly and continuously, ensuring that the sufferer feels comfortable, and generates foams that can ensure fine drug powder to be uniformly distributed, leading the drug to be uniformly distributed in the inner wall mucosa of the vagina; meanwhile, the foams last for a long time, which prolongs dramatically the even contact time of the drug and the mucosa of the vagina and extends the effect of the drug; furthermore, the vaginal effervescent tablet composition is easily washed out and more beneficial to the health of sufferers.

Description

technical field [0001] The invention relates to a vaginal effervescent tablet composition, in particular to a vaginal effervescent tablet composition containing solid lipid. Background technique [0002] Vaginal effervescent tablet is a kind of effervescent tablet administered intravaginally. The prescription contains an acid-base pair composed of acidic compounds and basic compounds as an effervescent disintegrant. It can absorb water, foam and disintegrate when it meets secretions in the vagina. Decomposition produces foam (carbon dioxide gas), and the fine powder of the drug is distributed in the foam to contact and absorb the vaginal mucosa. Vaginal effervescent tablets have now become an effective dosage form for the treatment of gynecological diseases. [0003] Many drugs are suitable for clinical use in the form of vaginal effervescent tablets for the treatment of various gynecological diseases, including: trichomonas, fungal, gonococcal infection and other vaginitis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/46A61K47/14A61K47/20A61K47/34A61K31/18A61K31/4164A61K31/7048A61K31/7056A61P15/02
Inventor 张建军高缘
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com